NOVARTIS INDIA Current Financial Leverage

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NI</div>
NOVARTIND -- India Stock  

INR 562.85  1.40  0.25%

NOVARTIS INDIA financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. NOVARTIS INDIA LTD financial risk is the risk to NOVARTIS INDIA stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Additionally, see the analysis of NOVARTIS INDIA Fundamentals Over Time.

Search Bonds


NOVARTIS INDIA Financial Leverage Rating

Total Macroaxis Rating
Not Rated
Average S&P Rating

NOVARTIS INDIA LTD Debt to Cash Allocation

The company has accumulated 682.9 M in total debt with debt to equity ratio (D/E) of 0.09, which may suggest the company is not taking enough advantage from borrowing. NOVARTIS INDIA LTD has a current ratio of 3.42, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Understending NOVARTIS INDIA Use of Financial Leverage

NOVARTIS INDIA financial leverage ratio helps in determining the effect of debt on the overall profitability of the company. It measures the total debt position of NOVARTIS INDIA, including all of NOVARTIS INDIA's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of NOVARTIS INDIA assets, the company is considered highly leveraged. Understanding the composition and structure of overall NOVARTIS INDIA debt and outstanding corporate bonds gives a good idea as to how risky the capital structure of a business and if it is worth investing in it. Please read more on our technical analysis page.
Novartis India Limited primarily trades in drugs and pharmaceuticals. The company was incorporated in 1947 and is headquartered in Mumbai, India. NOVARTIS INDIA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on Bombay Stock Exchange.

Did you try this?

Run Crypto Correlations Now


Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of NOVARTIS INDIA Fundamentals Over Time. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page